Have a personal or library account? Click to login
Somatic Implications in Hospitalized Patients with Chronic Schizophrenia Cover

Somatic Implications in Hospitalized Patients with Chronic Schizophrenia

Acta Medica Transilvanica
Volume 26 (2021): Issue 3 (September 2021)
By: Andreea Sălcudean,  Bianca-Eugenia Ősz,  Elena-Gabriela Strete,  Monica Kiss,  Maria-Dorina Paşca,  Cristina-Raluca Bodo,  Maria-Melania Lica,  Andreea-Georgiana Nan,  Marius-Cătălin Cosma and  Mariana Tilinca  
Open Access
|Nov 2021

References

  1. 1. Šimunović Filipčić I, Filipčić I. Schizophrenia and Physical Comorbidity. Psychiatr Danub. 2018 Jun;30(Suppl 4):152-157
    Search in Google ScholarBack to article
  2. 2. Laursen TM, Munk-Olsen T, Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One. 2011;6(9):e2459710.1371/journal.pone.0024597317346721935426
    Search in Google ScholarBack to article
  3. 3. Salcudean A. The autolitic risk in patients with schizophrenia. Acta Medica Transilvanica. 2011;16(3):481-483.
    Search in Google ScholarBack to article
  4. 4. Salcudean A, Sirbu E, Muresan D, Bodo C. Particular aspects of social integration among patients with schizophrenia. Acta Marisiensis - Seria Medica. 2021;67(1): 34-38.
    Search in Google ScholarBack to article
  5. 5. Salcudean A, Ferencz M, Sabau D, Gherman M. Clinical evolution of patients with schizophrenia associated with addictive disorders. Acta Marisiensis - Seria Medica. 2020;66(4):152-154.
    Search in Google ScholarBack to article
  6. 6. Siafis S, Tzachanis D, Samara M, Papazisis G. Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects. Curr Neuropharmacol. 2018;16(8):1210-1223.10.2174/1570159X15666170630163616618774828676017
    Search in Google ScholarBack to article
  7. 7. Dieset I, Andreassen OA, Haukvik UK. Somatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span. Schizophr Bull. 2016 Nov;42(6):1316-1319.10.1093/schbul/sbw028504952127033328
    Search in Google ScholarBack to article
  8. 8. Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment. 2012;2012:91619810.1155/2012/916198342045622966451
    Search in Google ScholarBack to article
  9. 9. Lehrer DS, Lorenz J. Anosognosia in schizophrenia: hidden in plain sight. Innov Clin Neurosci. 2014 May;11(5-6):10-7.
    Search in Google ScholarBack to article
  10. 10. Simonsen E, Newton-Howes G. Personality Pathology and Schizophrenia. Schizophr Bull. 2018 Oct 17;44(6):1180-118410.1093/schbul/sby053619249629688529
    Search in Google ScholarBack to article
  11. 11. Howell S, Yarovova E, Khwanda A, Rosen SD. Cardiovascular effects of psychotic illnesses and antipsychotic therapy. Heart (British Cardiac Society). 2019 Dec;105(24):1852-1859.10.1136/heartjnl-2017-31210731439658
    Search in Google ScholarBack to article
  12. 12. Farwell WR, Stump TE, Wang J, Tafesse E, L’Italien G, Tierney WM. Weight gain and new onset diabetes associated with olanzapine and risperidone. J Gen Intern Med. 2004 Dec;19(12):1200-5.10.1111/j.1525-1497.2004.40126.x149259615610330
    Search in Google ScholarBack to article
  13. 13. Bortolozzi A, Díaz-Mataix L, Scorza MC, Celada P, Artigas F. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J Neurochem. 2005 Dec;95(6):1597-607.10.1111/j.1471-4159.2005.03485.x16277612
    Search in Google ScholarBack to article
  14. 14. Reponen EJ, Tesli M, Dieset I, Steen NE, Vedal TSJ, Szabo A, et al. Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment. Front Psychiatry. 2021 May 28;12:623192.10.3389/fpsyt.2021.623192819270834122163
    Search in Google ScholarBack to article
  15. 15. Stoner SC. Management of serious cardiac adverse effects of antipsychotic medications. Ment Health Clin. 2018 Mar 23;7(6):246-254.10.9740/mhc.2017.11.246600773329955530
    Search in Google ScholarBack to article
  16. 16. Tuplin EW, Holahan MR. Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity. Curr Neuropharmacol. 2017 Nov 14;15(8):1192-1207.10.2174/1570159X15666170413115754
    Search in Google ScholarBack to article
  17. 17. Polcwiartek C, Sneider B, Graff C, Taylor D, Meyer J, Kanters JK, et al. The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach. Psychopharmacology (Berl). 2015 Sep;232(18):3297-30810.1007/s00213-015-4024-9
    Search in Google ScholarBack to article
  18. 18. Mota NE, Lima MS, Soares BG. Amisulpride for schizophrenia. Cochrane Database Syst Rev. 2002;2002(2):CD001357.
    Search in Google ScholarBack to article
  19. 19. Wang MT, Lin CW, Tsai CL, Wang YH, Lai JH, Yeh CB, et al. Use of antipsychotics and the risk of acute respiratory failure among adults: A disease risk score-matched nested case-control study. Br J Clin Pharmacol. 2020 Nov;86(11):2204-2216.10.1111/bcp.14321
    Search in Google ScholarBack to article
  20. 20. Gaillard R, Ouanas A, Spadone C, Llorca PM, Lôo H, Baylé FJ. Benzodiazépines et schizophrénie, revue de la littérature [Benzodiazepines and schizophrenia, a review of the literature]. Encephale. 2006 Nov-Dec;32(6 Pt 1):1003-10. French.10.1016/S0013-7006(06)76280-7
    Search in Google ScholarBack to article
  21. 21. Fukai M, Hirosawa T, Takahashi T, Kaneda R, Kikuchi M, Minabe Y. Clonazepam improves dopamine supersensitivity in a schizophrenia patient: a case report. Ther Adv Psychopharmacol. 2017 Mar;7(3):113-117.10.1177/2045125316681750535412828348731
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/amtsb-2021-0047 | Journal eISSN: 2285-7079 | Journal ISSN: 2285-7079
Journal RSS Feed
Language: English
Page range: 37 - 41
Submitted on: Jul 16, 2021
Accepted on: Sep 2, 2021
Published on: Nov 3, 2021
Published by: Lucian Blaga University of Sibiu
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
schizophrenia,
somatic comorbidity,
cardiovascular comorbidity,
GAFS
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2021 Andreea Sălcudean, Bianca-Eugenia Ősz, Elena-Gabriela Strete, Monica Kiss, Maria-Dorina Paşca, Cristina-Raluca Bodo, Maria-Melania Lica, Andreea-Georgiana Nan, Marius-Cătălin Cosma, Mariana Tilinca, published by Lucian Blaga University of Sibiu
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 26 (2021): Issue 3 (September 2021)Next article